We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of VTYX yet.

VTYX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2026, worth a combined $21K — down 100% from $472M a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of VTYX and 1 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $20.3K. The largest seller was Affinity Asset Advisors, exiting entirely with an estimated $58.6M sold.

  • 1 institutional investor held Ventyx Biosciences (VTYX) as of Q1 2026, down from 139 in Q4 2025.
  • Funds reported $21K of Ventyx Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 1 fund opened new Ventyx Biosciences positions in Q1 2026 and 138 closed out, a net change of -137 holders.
  • The largest Ventyx Biosciences buyer in Q1 2026 was IFP Advisors, an estimated $20.3K added.
  • The largest Ventyx Biosciences seller in Q1 2026 was Affinity Asset Advisors, an estimated $58.6M sold.

Based on aggregated 13F filings for Q1 2026.